DelveInsight

Recent Posts by DelveInsight:

The Growing Market for Chronic Lower Back Pain (CLBP)

Chronic lower back pain (CLBP) is the second leading cause of disability worldwide. The prevalence of CLBP in adults has grown significantly over the last ten years.

Topics: Pharmaceuticals Healthcare Industry Insights

The State of the Medical Marijuana Market in 2020

Cannabis culture is not new and is not restricted to recreational purposes. The use of cannabis, a.k.a. marijuana, for medicinal purposes such as joint pain, muscle spasms, gout, spinal cord injury, and insomnia, dates back to as early as 5000 BC.

Topics: Pharmaceuticals Industry Insights

Infographic: Non-Small Cell Lung Cancer (NSCLC) Market Insights

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and accounted for around 85% of all lung cancers in the United States.

Topics: Pharmaceuticals Industry Insights

Infographic: Acute Kidney Injury (AKI) Market Insights

Acute Kidney Injury (AKI) is a condition characterized by minor or complete loss of kidney function due to a sudden injury to kidneys. AKI is different from chronic kidney disease, wherein the kidney function is lost over a period of time.

Topics: Healthcare Industry Insights

Top Therapeutic Drugs Targeting the Novel Coronavirus COVID-19

The novel coronavirus, SARS-CoV-2, also known as COVID-19, has now become a pandemic, leaving all healthcare institutions and government officials baffled, and researchers and scientists on high alert.

Topics: Pharmaceuticals Industry Insights

4 Top New Drugs That Will Make Their Mark in the Coming Years

Every year several new drugs enter the pharma value chain. The launch of a new therapy or drug means a new treatment option for the patient pool and advancement in people’s quality of life.

Topics: Pharmaceuticals Industry Insights

Global Orphan Drug Market to Reach $120 Billion by 2018

Orphan disease, by definition, is “any disease that affects a small percentage of the general population.” These diseases are often life-threatening, chronic, progressive, degenerative, and disabling, while most of them are linked to a genetic disorder and remain undiagnosed.

Topics: Pharmaceuticals Healthcare Industry Insights

5 Potential Blockbuster Drugs to Watch in 2017-2018

The past few decades have witnessed several blockbuster drug performances in the pharma industry, changing the face of the industry as well as completely transforming the fate of many companies and stakeholders. The success of these drugs justifies the rigorous process of development, which is tough and economically draining.

Topics: Pharmaceuticals Industry Insights